MX9702210A - Procesos de racemisacion y transformacion asimetrica usados en la manufactura de levobupuvacaina y sus analogos. - Google Patents

Procesos de racemisacion y transformacion asimetrica usados en la manufactura de levobupuvacaina y sus analogos.

Info

Publication number
MX9702210A
MX9702210A MX9702210A MX9702210A MX9702210A MX 9702210 A MX9702210 A MX 9702210A MX 9702210 A MX9702210 A MX 9702210A MX 9702210 A MX9702210 A MX 9702210A MX 9702210 A MX9702210 A MX 9702210A
Authority
MX
Mexico
Prior art keywords
racemisation
levobupivacaine
analogues
manufacture
asymmetric transformation
Prior art date
Application number
MX9702210A
Other languages
English (en)
Inventor
Ulrich Conrad Dyer
Christopher James Lock
Martin Woods
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9504927.6A external-priority patent/GB9504927D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of MX9702210A publication Critical patent/MX9702210A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00—Asymmetric syntheses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B55/00—Racemisation; Complete or partial inversion

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of Radiation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Un proceso para la racemizacion de un compuesto de piperidin-2-carboxaniladaopticamente enriquecido, que comprende calentar el compuesto en presencia de una ácido alcanoico o arilalcanoico. Un proceso para la transformacion asimétrica de un compuesto, que comprende calentar el compuesto en presencia de un ácido como definio en lo anterior, un agente de resolucion de ácido y un cosolvente inerte.
MX9702210A 1994-09-23 1995-09-22 Procesos de racemisacion y transformacion asimetrica usados en la manufactura de levobupuvacaina y sus analogos. MX9702210A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94306962 1994-09-23
GBGB9504927.6A GB9504927D0 (en) 1995-03-10 1995-03-10 Racemisation and asymmetric transformation
PCT/GB1995/002247 WO1996009290A1 (en) 1994-09-23 1995-09-22 Racemisation and asymmetric transformation processes used in the manufacture of levobupivacaine and analogues thereof

Publications (1)

Publication Number Publication Date
MX9702210A true MX9702210A (es) 1998-05-31

Family

ID=26137306

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9702210A MX9702210A (es) 1994-09-23 1995-09-22 Procesos de racemisacion y transformacion asimetrica usados en la manufactura de levobupuvacaina y sus analogos.

Country Status (18)

Country Link
US (1) US5786484A (es)
EP (1) EP0782569B1 (es)
JP (1) JP3898220B2 (es)
KR (1) KR100393133B1 (es)
CN (1) CN1104416C (es)
AT (1) ATE214695T1 (es)
AU (1) AU695479B2 (es)
CA (1) CA2200490C (es)
DE (1) DE69525950T2 (es)
DK (1) DK0782569T3 (es)
ES (1) ES2173194T3 (es)
FI (1) FI117436B (es)
HU (1) HU216291B (es)
MX (1) MX9702210A (es)
NO (1) NO308074B1 (es)
PL (1) PL183204B1 (es)
PT (1) PT782569E (es)
WO (1) WO1996009290A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6384227B2 (en) 1995-01-18 2002-05-07 Darwin Discovery Ltd. Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agents
JP2000256359A (ja) * 1999-03-11 2000-09-19 Japan Science & Technology Corp 面性キラリティーを有する分子群の高選択的不斉変換法
US6288280B1 (en) * 1999-07-09 2001-09-11 Hoffmann-La Roche Inc. Racemization of atropisomeric bis(phosphine oxide) compounds
BR0002246A (pt) * 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
WO2001096301A1 (fr) 2000-06-14 2001-12-20 Toray Industries, Inc. Procedes de production de derive de piperidine racemique et de production de derive de piperidine a activite optique
DE10029851A1 (de) * 2000-06-16 2001-12-20 Boehringer Ingelheim Pharma Enantiomerentrennung von Piperidon-Derivaten unter gleichzeitiger in situ Racemisierung des unerwünschten Enantiomers
US6495694B2 (en) 2000-06-16 2002-12-17 Boehringer Ingelheim Pharma Kg Efficient separation of enantiomers of piperidone derivatives by precipitation of the desired eantiomer during in situ racemization of the unwanted enantiomer
BRPI0104491B8 (pt) * 2001-10-10 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica.
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
ES2350689T3 (es) 2002-12-13 2011-01-26 Durect Corporation Sistema de suministro de fármacos oral que comprende materiales vehículo líquidos de alta viscosidad.
WO2006033948A2 (en) 2004-09-17 2006-03-30 Durect Corporation Sustained local anesthetic composition containing preferably a sugar ester such as saib
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
WO2008066642A2 (en) 2006-11-03 2008-06-05 Durect Corporation Transdermal delivery systems comprising bupivacaine
JP2011506318A (ja) 2007-12-06 2011-03-03 デュレクト コーポレーション 経口医薬製剤
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
CN102093284B (zh) * 2010-12-29 2013-05-08 宜昌人福药业有限责任公司 富集哌啶-2-甲酰苯胺类旋光化合物的方法
WO2014144975A1 (en) 2013-03-15 2014-09-18 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
CN103664744B (zh) * 2013-11-30 2015-07-15 山东永泰化工有限公司 一种左布比卡因的制备方法
KR20210039987A (ko) * 2018-05-18 2021-04-12 쿠라 온콜로지, 인크. 티피파닙의 합성
JP2023515918A (ja) 2020-01-13 2023-04-17 デュレクト コーポレーション 不純物が低減された徐放性薬物送達システム及び関連の方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE451840B (sv) * 1986-01-03 1987-11-02 Astra Laekemedel Ab Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning

Also Published As

Publication number Publication date
NO308074B1 (no) 2000-07-17
EP0782569A1 (en) 1997-07-09
FI971202A (fi) 1997-03-21
CA2200490A1 (en) 1996-03-28
HUT77055A (hu) 1998-03-02
FI971202A0 (fi) 1997-03-21
PT782569E (pt) 2002-09-30
HU216291B (hu) 1999-06-28
CN1104416C (zh) 2003-04-02
ES2173194T3 (es) 2002-10-16
US5786484A (en) 1998-07-28
DK0782569T3 (da) 2002-07-22
AU3527995A (en) 1996-04-09
CN1159184A (zh) 1997-09-10
NO971358D0 (no) 1997-03-21
CA2200490C (en) 2007-01-09
JPH10505855A (ja) 1998-06-09
DE69525950T2 (de) 2002-09-19
PL319368A1 (en) 1997-08-04
DE69525950D1 (de) 2002-04-25
AU695479B2 (en) 1998-08-13
PL183204B1 (pl) 2002-06-28
ATE214695T1 (de) 2002-04-15
NO971358L (no) 1997-03-21
WO1996009290A1 (en) 1996-03-28
FI117436B (fi) 2006-10-13
JP3898220B2 (ja) 2007-03-28
EP0782569B1 (en) 2002-03-20
KR100393133B1 (ko) 2003-11-17

Similar Documents

Publication Publication Date Title
MX9702210A (es) Procesos de racemisacion y transformacion asimetrica usados en la manufactura de levobupuvacaina y sus analogos.
DE69921881D1 (de) L-Glutaminsäure-herstellendes Bakterium und Verfahren zur Herstellung von L-Glutaminsäure
DK0877090T3 (da) Fremgangsmåde til produktion af L-aminosyrer
DE60033151D1 (de) L-aminosäure herstellendes bakterium und verfahren zur herstellung von l-aminosäure
DE69941756D1 (de) L-Glutaminsäure herstellendes Bakterium und Verfahren zur Herstellung von Glutaminsäure
DE69530242D1 (de) Verfahren zur Herstellung von Glutaminsäure durch Fermentation
SG66356A1 (en) Process for production of acrylic acid
IL140419A0 (en) Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same
HUP0000728A3 (en) Salt of naphthyridine carboxylic acid derivative, process for producing it and pharmaceutical composition containing it
AU5707000A (en) Process for producing l-amino acid
DE69708818D1 (de) Verfahren zur Herstellung von Salpetersäure.
ZA200006161B (en) Method for production of acrylic acid and apparatus for production of acrylic acid.
DE69413946T2 (de) Verfahren zur Herstellung von hochreiner 2,6-Naphthalindicarbonsäure
AU5571100A (en) Process for producing l-amino acid
PL338215A1 (en) Method of obtaining 3-cyano-2,4-dichlorogeno-5-fluorobenzoic acids
KR950700870A (ko) 아디핀산의 제조 방법(process for preparing adipic acid)
DE59808082D1 (de) Verfahren zur herstellung von langkettigen glycin-n,n-diessigsäure-derivaten
AU4277001A (en) Process for producing l-amino acid via fermentation method
AU5707200A (en) Process for producing l-amino acid
DE69503196T2 (de) Verfahren zur Herstellung von Ranitdinbase in pharmazeutischer Reinheit
DE69609940T4 (de) Verfahren zur Herstellung von Adipinsäure
DE69524737T2 (de) 2-isoxazolin-derivate, verfahren zu deren herstellung sowie verfahren zur herstellung von verwandten verbindungen
DE69908169T2 (de) Verfahren zum herstellen von alpha-arylalkansäuren
UA32939A (uk) Сульфокамфокаїн, спосіб його виготовлення і спосіб підготовки обладнання для виготовлення сульфокамфокаїну
GB9607864D0 (en) Microorganism strain, process and apparatus for the manufacture of citric acid